1 / 6

Therapeutic Drug Monitoring Market Expected to Expand at a Steady CAGR through 2025

Some of the situations where measurement of drug dosage concentration is useful include, non-response at therapeutic dose, suboptimal tolerability, pharmacokinetic drug-drug interaction and drug adherence. TDM is regarded as a module of personalized medicine that interacts with various other disciplines such as pharmacogenomics and pharmacokinetics. Most commonly monitored drugs are digoxin, valproate and carbamazepine.

Ethan_smith
Download Presentation

Therapeutic Drug Monitoring Market Expected to Expand at a Steady CAGR through 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Therapeutic Drug Monitoring Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2015 Future Market Insights www.futuremarketinsights.com sales@futuremarketinsights.com

  2. Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Subscription Information Sector Coverage • Automotive and Transportation • Electronics, Semiconductor, and ICT • Retail and Consumer Products • Industrial Automation and Equipment • Customized Research • Syndicated Research • Investment Research • Social Media Research • Chemicals & Materials • Food and Beverages • Services and Utilities • Energy, Mining, Oil, and Gas Customized Research Syndicated Research Investment Research Social Media Research For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com

  3. Report Description Report Description Therapeutic drug monitoring is a branch of clinical chemistry and clinical pharmacology which aims at maintaining the drug concentration levels in the body fluids within the particular therapeutic range. The purpose of therapeutic drug monitoring is refining patient care by individually adjusting the drug dosage for better outcomes. Some of the situations where measurement of drug dosage concentration is useful include, non-response at therapeutic dose, suboptimal tolerability, pharmacokinetic drug-drug interaction and drug adherence. TDM is regarded as a module of personalized medicine that interacts with various other disciplines such as pharmacogenomics and pharmacokinetics. Most commonly monitored drugs are digoxin, valproate and carbamazepine. The global therapeutic drug monitoring market showed significant growth over the last few years and is projected to grow at a robust CAGR during the forecast period. Therapeutic Drug Monitoring Market: Drivers and Restraints Therapeutic drug monitoring is driven by various key factors which include, ageing population with better health care services, increasing demand for genetic testing, increased government and private sector participation in therapeutic drug monitoring markets, rise in drug profiling. Browse Full Report@http://www.futuremarketinsights.com/reports/therapeutic-drug-monitoring-market

  4. Report Description Report Description Ongoing problems with reimbursement, retrenchment in the hospital fields and a weak global economy. Fluctuating exchange rates further weakens the global market. Therapeutic Drug Monitoring Market: Segmentation Global therapeutic drug monitoring market is segmented on the basis of product type as following: Antibiotics Anticonvulsants Antiarrhythmic Antineoplastic Bronchodilators Immunosuppressive HIV/AIDS drugs Therapeutic drug monitoring market is further segmented on the basis of technology as: Spectrometry Chromatography Electrophoresis

  5. Report Description Report Description Request Free Sample Report@http://www.futuremarketinsights.com/reports/sample/rep-gb-953 Therapeutic Drug Monitoring Market: Overview With the advancement of technology and increase incidence in disease population, therapeutic drug monitoring, is gaining wide acceptance as a method of choice among patients. This market is expected to grow at a healthy CAGR in the forecast period (2015-2025). In the upcoming years, the TDM market will undergo significant transformation. These alterations will be done by convergence of new and more stringent regulations improvements in diagnostic technologies, automation and system engineering. Therapeutic Drug Monitoring Market: Region-wise Outlook Depending on geographic regions, therapeutic drug monitoring market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. In terms of geography, North America dominates the therapeutic drug monitoring market, followed by Europe. During the earlier stages of this market development growth rates were higher, while the value of the market was relatively low. As the market value started to rise the annual growth rate declined slightly, but is expected to increase again as the market develops and the advantages of therapeutic drug monitoring is appreciated in the established markets and as the techniques and products appear in the emerging market.

  6. Thank You! To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For other queries contact: Mr. Sudip Saha Future Market Insights:616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 | D: +1-845-579-5705

More Related